Share

Clinical Studies (3)

  • Racco : Study aims to implement a rapid diagnostic tool to reduce the burden of antibiotic therapies and potentially apply early respiratory isolation measures and infection control strategies
  • Del Borgo : Study aims to evaluate the effectiveness and tolerability of three antiviral drugs - molnupiravir, remdesivir, and nirmatrelvir/ritonavir - in treating mild-to-moderate COVID-19 in high-risk patients in a real-life setting
  • mpox-ICONA : Study aims to assess mpox disease, which recognises an epidemiological network that overlaps with HIV. To identify predictors of severe evolution and disease duration in mpox cases, as well as to test the association between mpox severity and viral load in biological fluids

Study Data

  • Adults (18-64 years)
  • General population
  • Elderly (≥65 years)
  • Infants (<1 year)
  • Fragile population
  • Adolescents (12-17 years)
  • Children (1-11 years)
  • People at high risk of STIs
  • People living with HIV
  • Hospital
  • Outpatient clinic
  • Infectious diseases unit
  • SARS-CoV-2
  • Monkeypox virus
  • Respiratory syncytial virus
  • Influenza virus
  • Adenovirus
  • Rhinovirus
  • Human metapneumovirus
  • Parainfluenza Virus
  • Enterovirus
  • Bordetella pertussis
  • Seasonal coronavirus
  • Bordetella parapertussis
  • Chlamydia pneumoniae
  • Mycoplasma pneumoniae
  • Acute COVID-19
  • Mpox
  • Respiratory syncytial virus infection
  • Influenza
  • COVID-19
  • Adenovirus infection
  • Rhinovirus infection
  • Enterovirus infection
  • Human metapneumovirus infection
  • Parainfluenza
  • Bordetella parapertussis infection
  • Bordetella pertussis infection
  • Chlamydia pneumoniae infection
  • Mycoplasma pneumoniae infection
  • Pharmacological intervention
  • Antivirals
  • Remdesivir
  • Nirmatrelvir/Ritonavir
  • Molnupiravir
  • Diagnostics
  • Point of care tests

Other information

If you would like to contact the site, please email: ccb@ateneo.univr.it

The data is updated up to